![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
(51) | INT.CL. | A61K 31/535 | |
A61K 9/00 | |||
A61K 9/48 | |||
A61K 47/14 |
(11) | Patento numeris | 1054674 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 99907077.4 |
Europos patento paraiškos padavimo data | 1999-02-17 | |
(97) | Europos patento paraiškos paskelbimo data | 2000-11-29 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2006-11-22 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/US1999/003318 |
Data | 1999-02-17 |
(87) | Numeris | WO 1999/040921 |
Data | 1999-08-19 |
(30) | Numeris | Data | Šalis |
74881 P | 1998-02-17 | US |
(72) |
BAHAL, Surendra, M., US
MAURIN, Michael, B., US
|
(73) |
Bristol-Myers Squibb Pharma Company,
PO Box 4000, Princeton, New Jersey 08443-4000,
US
|
(54) | ORAL LIQUID FORMULATIONS OF BENZOXAZINONES HIV REVERSE TRANSCRIPTASE INHIBITORS |
ORAL LIQUID FORMULATIONS OF BENZOXAZINONES HIV REVERSE TRANSCRIPTASE INHIBITORS |